Does TRASTUZUMAB DERUXTECAN Cause Infection? 41 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Infection have been filed in association with TRASTUZUMAB DERUXTECAN (Enhertu). This represents 1.5% of all adverse event reports for TRASTUZUMAB DERUXTECAN.
41
Reports of Infection with TRASTUZUMAB DERUXTECAN
1.5%
of all TRASTUZUMAB DERUXTECAN reports
5
Deaths
17
Hospitalizations
How Dangerous Is Infection From TRASTUZUMAB DERUXTECAN?
Of the 41 reports, 5 (12.2%) resulted in death, 17 (41.5%) required hospitalization.
Is Infection Listed in the Official Label?
Yes, Infection is listed as a known adverse reaction in the official FDA drug label for TRASTUZUMAB DERUXTECAN.
What Other Side Effects Does TRASTUZUMAB DERUXTECAN Cause?
Death (384)
Off label use (258)
Nausea (251)
Myelosuppression (242)
Fatigue (186)
Malignant neoplasm progression (171)
Vomiting (140)
Diarrhoea (132)
Interstitial lung disease (130)
Pneumonitis (125)
What Other Drugs Cause Infection?
ADALIMUMAB (11,552)
METHOTREXATE (10,406)
ETANERCEPT (10,379)
RITUXIMAB (9,575)
ABATACEPT (7,821)
TOCILIZUMAB (7,349)
PREDNISONE (6,334)
TOFACITINIB (6,332)
INFLIXIMAB (6,122)
CERTOLIZUMAB PEGOL (5,954)
Which TRASTUZUMAB DERUXTECAN Alternatives Have Lower Infection Risk?
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-DKST
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-DTTB
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB EMTANSINE
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-PKRB
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-QYYP